These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15708311)

  • 1. Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules.
    Westendorf AM; Gunzer F; Deppenmeier S; Tapadar D; Hunger JK; Schmidt MA; Buer J; Bruder D
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):373-84. PubMed ID: 15708311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy--a review].
    Xia P; Zhu J; Zhu G
    Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):538-44. PubMed ID: 24028055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
    Schultz M; Watzl S; Oelschlaeger TA; Rath HC; Göttl C; Lehn N; Schölmerich J; Linde HJ
    J Microbiol Methods; 2005 Jun; 61(3):389-98. PubMed ID: 15767015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs.
    Duncker SC; Lorentz A; Schroeder B; Breves G; Bischoff SC
    Vet Immunol Immunopathol; 2006 Jun; 111(3-4):239-50. PubMed ID: 16530848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.
    Buddenborg C; Daudel D; Liebrecht S; Greune L; Humberg V; Schmidt MA
    Int J Med Microbiol; 2008 Jan; 298(1-2):105-14. PubMed ID: 17936683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.
    Sturm A; Rilling K; Baumgart DC; Gargas K; Abou-Ghazalé T; Raupach B; Eckert J; Schumann RR; Enders C; Sonnenborn U; Wiedenmann B; Dignass AU
    Infect Immun; 2005 Mar; 73(3):1452-65. PubMed ID: 15731043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany.
    Kleta S; Steinrück H; Breves G; Duncker S; Laturnus C; Wieler LH; Schierack P
    J Appl Microbiol; 2006 Dec; 101(6):1357-66. PubMed ID: 17105567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice.
    Stritzker J; Weibel S; Hill PJ; Oelschlaeger TA; Goebel W; Szalay AA
    Int J Med Microbiol; 2007 Jun; 297(3):151-62. PubMed ID: 17448724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.
    Guzy C; Paclik D; Schirbel A; Sonnenborn U; Wiedenmann B; Sturm A
    Int Immunol; 2008 Jul; 20(7):829-40. PubMed ID: 18448456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917.
    Trebichavsky I; Splichal I; Rada V; Splichalova A
    Nutr Rev; 2010 Aug; 68(8):459-64. PubMed ID: 20646223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.
    Altenhoefer A; Oswald S; Sonnenborn U; Enders C; Schulze J; Hacker J; Oelschlaeger TA
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):223-9. PubMed ID: 15039098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells.
    Westendorf AM; Fleissner D; Deppenmeier S; Gruber AD; Bruder D; Hansen W; Liblau R; Buer J
    Gastroenterology; 2006 Aug; 131(2):510-24. PubMed ID: 16890605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal epithelial antigen induces CD4+ T cells with regulatory phenotype in a transgenic autoimmune mouse model.
    Westendorf AM; Bruder D; Hansen W; Buer J
    Ann N Y Acad Sci; 2006 Aug; 1072():401-6. PubMed ID: 17057222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.
    Ukena SN; Westendorf AM; Hansen W; Rohde M; Geffers R; Coldewey S; Suerbaum S; Buer J; Gunzer F
    BMC Med Genet; 2005 Dec; 6():43. PubMed ID: 16351713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.
    Grabig A; Paclik D; Guzy C; Dankof A; Baumgart DC; Erckenbrecht J; Raupach B; Sonnenborn U; Eckert J; Schumann RR; Wiedenmann B; Dignass AU; Sturm A
    Infect Immun; 2006 Jul; 74(7):4075-82. PubMed ID: 16790781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
    Isolauri E; Salminen S;
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S91-6. PubMed ID: 18542035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microecology in chronic inflammatory bowel diseases.
    Guarner F; Casellas F; Borruel N; Antolín M; Videla S; Vilaseca J; Malagelada JR
    Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S34-8. PubMed ID: 12556945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.